To demonstrate whether BATF2-EVs have inhibitory effects on SDF-1α, we subcutaneously injected U251-Ctrl and U251-BATF2 supernatant-derived EVs per 3 d after 7 d of U251 tumour establishment. Here, BATF2 is linked to neoplasm.